MODERATE TO SEVERE ASTHMA
Clinical trials for MODERATE TO SEVERE ASTHMA explained in plain language.
Never miss a new study
Get alerted when new MODERATE TO SEVERE ASTHMA trials appear
Sign up with your email to follow new studies for MODERATE TO SEVERE ASTHMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New asthma shot aims to help patients breathe easier
Disease control Not yet recruitingThis study is testing an investigational injection called RC1416 to see if it can help adults with moderate to severe asthma breathe better and have fewer serious asthma attacks. About 195 participants will receive either the drug or a placebo to compare results. The main goal is…
Matched conditions: MODERATE TO SEVERE ASTHMA
Phase: PHASE2 • Sponsor: Nanjing RegeneCore Biotech Co., Ltd. • Aim: Disease control
Last updated Apr 04, 2026 03:50 UTC
-
New asthma drug aims to cut severe attacks in Half-Year trial
Disease control Not yet recruitingThis study is testing an investigational injection called CM326 to see if it can reduce severe asthma flare-ups and improve lung function and quality of life in adults with moderate to severe asthma. About 230 participants will receive either CM326 or a placebo injection for 52 w…
Matched conditions: MODERATE TO SEVERE ASTHMA
Phase: PHASE3 • Sponsor: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
New pill targets root of asthma inflammation in global trial
Disease control Not yet recruitingThis study is testing an experimental pill called linvemastat as an add-on treatment for adults whose moderate-to-severe asthma isn't fully controlled by their standard inhalers. About 135 participants will take either the new drug or a placebo pill daily for 16 weeks while conti…
Matched conditions: MODERATE TO SEVERE ASTHMA
Phase: PHASE2 • Sponsor: Foresee Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC